▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #677 by analyst upside · 2026-08-12
AVTX
Avalo Therapeutics, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+126.8%
implied upside to consensus target
Current Price $19.47
Consensus Target $44.15
Bull Target $60.0
Bear Target $30.0
Analysts Covering 13
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
11
Hold
0
Sell
0
52-Week Low $8.41
52-Week High $24.27
YTD Return +14.4%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-4.41
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $8.41
52-Week High $24.27
Current Price $19.47
Bear Target $30.0
Bull Target $60.0
● Now $19.47 ● Target $44.15
TRADING DATA
Avg Volume 1.5M
YTD Return +14.4%
Analyst Count 13
Consensus Buy
Upside to Target +126.8%
Last Updated 2026-08-12

ANALYST SUMMARY

Avalo Therapeutics, Inc. (AVTX) is currently trading at $19.47 with a Wall Street consensus price target of $44.15, implying potential upside of 126.8% over the next 12 months. 13 analysts currently cover AVTX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $60.0, while the most cautious has a target of $30.0.

AVTX operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 14.4% year-to-date and is currently trading near the upper end of its 52-week range of $8.41 – $24.27.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

OMER +142.6%
Omeros Corporation
$984M · P/E 11.9x · Hold
GTBIF +119.8%
Green Thumb Industries Inc.
$2B · P/E 13.5x · Buy
ZVRA +120.5%
Zevra Therapeutics, Inc.
$673M · P/E 12.2x · Buy
COLL +97.1%
Collegium Pharmaceutical, Inc.
$843M · P/E 20.5x · Buy
CRMD +105.5%
CorMedix Inc.
$573M · P/E 3.4x · Strong Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for AVTX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BTIG reit
Buy → Buy 2026-06-16 38% win rate (8 calls)
B of A Securities ● Initiated
Buy 2026-06-12 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-05-14 Building track record
Wedbush - Reiterated
Outperform → Outperform 2026-05-14 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-05-14 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-05-14 31% win rate (48 calls)
Piper Sandler - Reiterated
Overweight → Overweight 2026-05-11 14% win rate (7 calls)
Citizens - Reiterated
Market Outperform → Market Outperform 2026-05-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
47
out of 100
Coverage depth
20/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →